SCHEMBL17656295

SCHEMBL17656295

C=C(N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3cc(Br)ccc3c2)[nH]1)C(C)C)OC

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.47
CYP2C9 P11712 6/20 0.47
KCNH2 Q12809 5/20 0.47
NR1I2 O75469 2/20 0.47
ABCB11 O95342 1/20 0.47
OPRK1 P41145 1/20 0.47
CYP1A2 P05177 3/20 0.44
CYP2D6 P10635 2/20 0.43
PRCP P42785 1/20 0.38
PDF Q9HBH1 3/20 0.34
GSK3B P49841 1/20 0.32
DYRK1A Q13627 1/20 0.32
HDAC8 Q9BY41 2/20 0.31
HDAC6 Q9UBN7 2/20 0.31
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL204788 0.92 CYP3A4 (0.57) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL15368433 0.92 CYP3A4 (0.57) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL2707557 0.92 CYP3A4 (0.57) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL3763658 0.91 CYP3A4 (0.46) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL2708868 0.87 CYP3A4 (0.62) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL15368522 0.85 PRCP (0.42) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL204522 0.85 CYP3A4 (0.64) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL18463098 0.85 CYP3A4 (0.64) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL2710862 0.85 CYP3A4 (0.64) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL14982507 0.84 CYP3A4 (0.58) CYP3A4CYP2C9KCNH2NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3002281-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2016-04-06 EP disclosed